Data as of Oct 31
| +0.06 / +0.22%|
The 6 analysts offering 12-month price forecasts for Auspex Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 50.00 and a low estimate of 37.00. The median estimate represents a +51.29% increase from the last price of 27.10.
The current consensus among 6 polled investment analysts is to Buy stock in Auspex Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.